CD56neg CD16+ cells represent a distinct mature NK cell subset with altered phenotype and are associated with adverse clinical outcome upon expansion in AML.
Preprint
- 10 August 2024
- preprint
- Published by Springer Nature in Research Square
Abstract
CD56neg CD16+ Natural Killer (NK) cells have been reported to expand in chronic diseases and acute myeloid leukemia (AML). However, their biological role is still unclear. Using mass cytometry, spectral flow cytometry, bulk RNA-seq and in vitro assays, we characterized CD56neg CD16+ NK cells that expand in AML. We confirmed that CD56neg CD16+ NK cells represent a unique NK cell subset coexpressing Eomes and T-bet. CD56neg CD16+ NK cells could recover CD56 expression in vitro where they displayed unaltered NK cell functions. We previously demonstrated that CD56neg CD16+ NK cells expansion at diagnosis was associated with adverse clinical outcome in AML. Here, we validated our findings in a validation cohort of N=38 AML patients. AML patients with CD56neg CD16+ NK cells expansion at diagnosis had decreased overall survival (HR[CI95]=5.5[1.2-24.5], p=0.0251) and relapse-free survival (HR[CI95]=13.1[1.9-87.5], p=0.0079) compared to AML patients without expansion after 36 months follow-up. RNA-seq unveiled that CD56neg CD16+ NK cells were mature circulating NK cells with functional capacities. Upon expansion, CD56neg CD16+ NK cells from AML patients showed altered proteomic phenotype, with high expression of TIM-3 and Siglec-7. Taken together, our results suggest that CD56neg CD16+ NK cells are a relevant target for future NK-cell-based immunotherapies.Keywords
All Related Versions
This publication has 48 references indexed in Scilit:
- Single‐cell transcriptome profiling reveals the key role of ZNF683 in natural killer cell exhaustion in multiple myelomaClinical and Translational Medicine, 2022
- Acute myeloid leukemia: current progress and future directionsBlood Cancer Journal, 2021
- A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cellsCell, 2021
- Proteome analysis of human CD56neg NK cells reveals a homogeneous phenotype surprisingly similar to CD56dim NK cellsEuropean Journal of Immunology, 2018
- Natural Killer Cell Education and the Response to Infection and Cancer Therapy: Stay TunedTrends in Immunology, 2018
- T‐bet and Eomes govern differentiation and function of mouse and human NK cells and ILC1European Journal of Immunology, 2018
- Siglec-10 is associated with survival and natural killer cell dysfunction in hepatocellular carcinomaJournal of Surgical Research, 2015
- Expression and regulation of complement receptors by human natural killer cellsImmunobiology, 2014
- Cytokine profiles in acute myeloid leukemia patients at diagnosis: Survival is inversely correlated with IL-6 and directly correlated with IL-10 levelsCytokine, 2013
- Natural killer cell immune escape in acute myeloid leukemiaLeukemia, 2012